Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
October 26, 2021 at 04:54 am EDT
Share
Xinjiang Baihuacun Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 184.38 million compared to CNY 81.62 million a year ago. Revenue was CNY 184.38 million compared to CNY 81.62 million a year ago. Net income was CNY 54.9 million compared to net loss of CNY 41.88 million a year ago. Basic earnings per share from continuing operations was CNY 0.1463 compared to basic loss per share from continuing operations of CNY 0.1065 a year ago. Diluted earnings per share from continuing operations was CNY 0.1463 compared to diluted loss per share from continuing operations of CNY 0.1065 a year ago.
Xinjiang Bai Hua Cun Pharma Tech Co Ltd is a China-based company principally engaged in pharmaceutical services. The Company's main business is the research and development, registration and application of small molecule chemicals and the development of peptide drugs. The Company is engaged in the early discovery and screening of new drugs, drug clinical trials, biological sample analysis, medicine testing services, active pharmaceutical ingredient (API) and intermediate supply. The Company is also engaged in leasing and property services. The Company mainly conducts business within the domestic market.
XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD 
